Abstract PR14: Phase I trial of first-in-class ataxia telangiectasia-mutated and Rad3-related (ATR) inhibitor VX-970 as monotherapy (mono) or in combination with carboplatin (CP) in advanced cancer patients (pts) with preliminary evidence of target modulation and antitumor activity

Name: Work Video:
Duration: 3 min 30 s
Timothy A. Yap; Maria J. de Miguel; Brent O’Carrigan; Desam Roda; Dionysis Papadatos-Pastos; David Lorente; Nina Tunariu; Raquel Pérez López; Sasha Gayle; Ruth Riisnaes; Ines Figueiredo; Susana Miranda; Suzanne Carreira; Fang Yang; Sharon Karan; Marina S. Penney; John R. Pollard; L Rhoda Molife; Udai Banerji; Mohammed Asmal; Scott Z. Fields; Johann S. de Bono
{'id': 'https://openalex.org/W2346506773', 'doi': 'https://doi.org/10.1158/1535-7163.targ-15-pr14', 'title': 'Abstract PR14: Phase I trial of first-in-class ataxia telangiectasia-mutated and Rad3-related (ATR) inhibitor VX-970 as monotherapy (mono) or in combination with carboplatin (CP) in advanced cancer patients (pts) with preliminary evidence of target modulation and antitumor activity', 'display_name': 'Abstract PR14: Phase I trial of first-in-class ataxia telangiectasia-mutated and Rad3-related (ATR) inhibitor VX-970 as monotherapy (mono) or in combination with carboplatin (CP) in advanced cancer patients (pts) with preliminary evidence of target modulation and antitumor activity', 'publication_year': 2015, 'publication_date': '2015-12-01', 'ids': {'openalex': 'https://openalex.org/W2346506773', 'doi': 'https://doi.org/10.1158/1535-7163.targ-15-pr14', 'mag': '2346506773'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-15-pr14', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5068368047', 'display_name': 'Timothy A. Yap', 'orcid': 'https://orcid.org/0000-0002-2154-3309'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Timothy A. Yap', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077902877', 'display_name': 'Maria J. de Miguel', 'orcid': 'https://orcid.org/0000-0002-9366-8602'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}, {'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Maria J. de Miguel Luken', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I4210121186']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062486859', 'display_name': 'Brent O’Carrigan', 'orcid': 'https://orcid.org/0000-0001-8187-6298'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': "Brent O'Carrigan", 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000986686', 'display_name': 'Desam Roda', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}, {'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Desam Roda', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I4210121186']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051179100', 'display_name': 'Dionysis Papadatos-Pastos', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Dionysis Papadatos-Pastos', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028760417', 'display_name': 'David Lorente', 'orcid': 'https://orcid.org/0000-0001-7550-0657'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'David Lorente', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056339622', 'display_name': 'Nina Tunariu', 'orcid': 'https://orcid.org/0000-0001-6656-3699'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Nina Tunariu', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103501093', 'display_name': 'Raquel Pérez López', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Raquel Perez Lopez', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052600735', 'display_name': 'Sasha Gayle', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Sasha Gayle', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066136399', 'display_name': 'Ruth Riisnaes', 'orcid': 'https://orcid.org/0000-0002-8924-302X'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Ruth Riisnaes', 'raw_affiliation_strings': ['2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104110102', 'display_name': 'Ines Figueiredo', 'orcid': 'https://orcid.org/0009-0007-7334-7362'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Ines Figueiredo', 'raw_affiliation_strings': ['2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062820099', 'display_name': 'Susana Miranda', 'orcid': 'https://orcid.org/0000-0002-5936-2706'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Susana Miranda', 'raw_affiliation_strings': ['2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085732690', 'display_name': 'Suzanne Carreira', 'orcid': 'https://orcid.org/0000-0002-5077-5379'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Suzanne Carreira', 'raw_affiliation_strings': ['2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '2Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083292183', 'display_name': 'Fang Yang', 'orcid': 'https://orcid.org/0000-0003-3465-6465'}, 'institutions': [{'id': 'https://openalex.org/I61970326', 'display_name': 'Vertex Pharmaceuticals (United States)', 'ror': 'https://ror.org/00anb1726', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I61970326']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Fang Yang', 'raw_affiliation_strings': ['3Vertex Pharmaceuticals Incorporated, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '3Vertex Pharmaceuticals Incorporated, Boston, MA;', 'institution_ids': ['https://openalex.org/I61970326']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108876654', 'display_name': 'Sharon Karan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I61970326', 'display_name': 'Vertex Pharmaceuticals (United States)', 'ror': 'https://ror.org/00anb1726', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I61970326']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sharon Karan', 'raw_affiliation_strings': ['3Vertex Pharmaceuticals Incorporated, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '3Vertex Pharmaceuticals Incorporated, Boston, MA;', 'institution_ids': ['https://openalex.org/I61970326']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110502323', 'display_name': 'Marina S. Penney', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I61970326', 'display_name': 'Vertex Pharmaceuticals (United States)', 'ror': 'https://ror.org/00anb1726', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I61970326']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Marina Penney', 'raw_affiliation_strings': ['3Vertex Pharmaceuticals Incorporated, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '3Vertex Pharmaceuticals Incorporated, Boston, MA;', 'institution_ids': ['https://openalex.org/I61970326']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085072340', 'display_name': 'John R. Pollard', 'orcid': 'https://orcid.org/0009-0001-7995-9606'}, 'institutions': [{'id': 'https://openalex.org/I4210127480', 'display_name': 'Vertex Pharmaceuticals (United Kingdom)', 'ror': 'https://ror.org/03fs5jd74', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I4210127480', 'https://openalex.org/I61970326']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'John Pollard', 'raw_affiliation_strings': ['4Vertex Pharmaceuticals Incorporated, Milton Park, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '4Vertex Pharmaceuticals Incorporated, Milton Park, United Kingdom.', 'institution_ids': ['https://openalex.org/I4210127480']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074632224', 'display_name': 'L Rhoda Molife', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'L. Rhoda Molife', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032401979', 'display_name': 'Udai Banerji', 'orcid': 'https://orcid.org/0000-0003-1503-3123'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Udai Banerji', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055726573', 'display_name': 'Mohammed Asmal', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I61970326', 'display_name': 'Vertex Pharmaceuticals (United States)', 'ror': 'https://ror.org/00anb1726', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I61970326']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mohammed Asmal', 'raw_affiliation_strings': ['3Vertex Pharmaceuticals Incorporated, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '3Vertex Pharmaceuticals Incorporated, Boston, MA;', 'institution_ids': ['https://openalex.org/I61970326']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111813748', 'display_name': 'Scott Z. Fields', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I61970326', 'display_name': 'Vertex Pharmaceuticals (United States)', 'ror': 'https://ror.org/00anb1726', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I61970326']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Scott Z. Fields', 'raw_affiliation_strings': ['3Vertex Pharmaceuticals Incorporated, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '3Vertex Pharmaceuticals Incorporated, Boston, MA;', 'institution_ids': ['https://openalex.org/I61970326']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5072378199', 'display_name': 'Johann S. de Bono', 'orcid': 'https://orcid.org/0000-0002-2034-595X'}, 'institutions': [{'id': 'https://openalex.org/I4210121186', 'display_name': 'Royal Marsden Hospital', 'ror': 'https://ror.org/034vb5t35', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038', 'https://openalex.org/I4210121186']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Johann S. de Bono', 'raw_affiliation_strings': ['1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom;', 'institution_ids': ['https://openalex.org/I4210121186', 'https://openalex.org/I142947616']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.758, 'has_fulltext': False, 'cited_by_count': 17, 'citation_normalized_percentile': {'value': 0.706713, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '14', 'issue': '12_Supplement_2', 'first_page': 'PR14', 'last_page': 'PR14'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10583', 'display_name': 'Cancer-related Molecular Pathways', 'score': 0.9776, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9519, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.6853832}, {'id': 'https://openalex.org/keywords/carboplatin', 'display_name': 'Carboplatin', 'score': 0.6616402}], 'concepts': [{'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.6853832}, {'id': 'https://openalex.org/C2781451048', 'wikidata': 'https://www.wikidata.org/wiki/Q415588', 'display_name': 'Carboplatin', 'level': 4, 'score': 0.6616402}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.62547135}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.46644732}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.46039173}, {'id': 'https://openalex.org/C143425029', 'wikidata': 'https://www.wikidata.org/wiki/Q5205747', 'display_name': 'DNA damage', 'level': 3, 'score': 0.4448627}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.44155025}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.43661523}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.4010295}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3740598}, {'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.24786386}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.20466071}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.13823986}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.077803075}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-15-pr14', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.82, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4311628015', 'https://openalex.org/W4285398041', 'https://openalex.org/W3191427281', 'https://openalex.org/W2349164817', 'https://openalex.org/W2131322929', 'https://openalex.org/W2087016115', 'https://openalex.org/W2070691864', 'https://openalex.org/W1976837208', 'https://openalex.org/W1914432880', 'https://openalex.org/W1718066741'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'ATR': [2, 24, 33, 41, 89, 101], 'mediates': [3], 'the': [4, 58, 83, 682], 'homologous': [5], 'recombination': [6], 'DNA': [7, 59], 'repair': [8, 61], 'pathway': [9, 63], 'and': [10, 20, 38, 85, 93, 106, 155, 160, 183, 185, 253, 317, 350, 356, 372, 399, 424, 457, 481, 509, 545, 556, 577, 582, 650, 675, 688], 'cellular': [11], 'response': [12, 474], 'to': [13, 81, 97, 107, 475, 525], 'replication': [14, 52], 'stress.': [15], 'VX-970': [16, 73, 127, 156, 172, 236, 284, 297, 307, 318, 395, 428, 476, 495, 510, 539, 559, 654], 'is': [17, 391, 540], 'a': [18, 163, 167], 'potent': [19], 'selective': [21], 'inhibitor': [22, 42, 90, 653], 'of': [23, 32, 51, 72, 87, 100, 162, 231, 279, 463, 502, 521, 553, 646, 672, 681], '(Ki': [25], '&amp;lt;0.2': [26], 'nM)': [27], 'that': [28], 'showed': [29, 426], 'enhanced': [30], 'synergy': [31], 'inhibition': [34, 102], 'with': [35, 48, 94, 113, 133, 408, 421, 465, 494, 548, 550, 585, 661, 669], 'cytotoxic': [36], 'chemotherapy': [37], 'potential': [39], 'mono': [40, 92, 128, 477, 496], 'activity': [43], 'in': [44, 57, 103, 118, 130, 166, 177, 440, 497, 513, 546, 564, 569, 583, 659, 664], 'tumor': [45, 104, 173, 443, 571], 'cell': [46, 579], 'lines': [47, 230, 278, 462], 'high': [49], 'levels': [50, 188], 'stress,': [53], 'such': [54], 'as': [55, 91, 543, 655], 'defects': [56], 'damage': [60], '(DDR)': [62], '(e.g.': [64], 'ATM': [65, 467], 'loss).': [66], 'A': [67], 'phase': [68, 566], 'I': [69, 644], 'dose-escalation': [70, 169], 'trial': [71, 484, 645], '(sponsored': [74], 'by': [75, 190, 469], 'Vertex': [76], 'Pharmaceuticals': [77], 'Incorporated)': [78], 'was': [79, 406, 438, 492], 'undertaken': [80], 'assess': [82], 'safety': [84], 'tolerability': [86], 'an': [88], 'DNA-damaging': [95], 'chemotherapy,': [96], 'show': [98], 'evidence': [99, 552, 671], 'tissue,': [105], 'explore': [108], 'antitumor': [109, 557, 676], 'activity.': [110, 558, 677], 'Methods:': [111], 'Pts': [112], 'advanced': [114, 452, 665], 'solid': [115], 'tumors': [116], 'enrolled': [117], '2': [119, 159, 344], 'sequential': [120], 'parts.': [121], 'Part': [122, 147, 211, 260, 329, 342], 'A:': [123], 'pts': [124, 149, 181, 194, 214, 263, 345, 499, 530], 'received': [125, 150, 235, 283], 'IV': [126], 'weekly': [129], 'single-pt': [131], 'cohorts,': [132], '3+3': [134, 168], 'cohorts': [135], 'initiated': [136], 'if': [137], 'grade': [138], '(G)': [139], '≥2': [140], 'VX-970-related': [141], 'adverse': [142], 'events': [143], '(AEs)': [144], 'were': [145, 175, 195, 339, 366, 384, 417, 517], 'observed.': [146], 'B:': [148], 'CP': [151, 179, 288, 301, 311, 322, 512], 'on': [152, 157, 412, 483, 534], 'day': [153], '1': [154, 295], 'days': [158], '9': [161], '21-day': [164], 'cycle': [165], 'design.': [170], 'Paired': [171], 'biopsies': [174, 444], 'obtained': [176], 'selected': [178], 'treated': [180], 'pre-': [182], 'post-VX-970,': [184], 'pS345': [186], 'Chk1': [187, 436], 'assessed': [189], 'IHC.': [191], 'Results:': [192], '25': [193], 'treated;': [196], 'M/F': [197], '10/15;': [198], 'median': [199, 228, 276, 404], 'age': [200], '67': [201], 'yr': [202], '(range': [203], '49-76': [204], 'yr);': [205], 'ECOG': [206], 'PS': [207], '0/1:': [208], '11/14.': [209], 'In': [210, 259, 328, 341], 'A,': [212, 330], '11': [213, 505], '(colorectal': [215], '[CRC;': [216], 'n': [217], '=': [218, 222, 226, 233, 241, 246, 251, 257, 266, 270, 274, 281, 291, 304, 314, 325, 353, 360, 369, 375, 504, 523], '2];': [219, 223, 271], 'mesothelioma': [220], '[n': [221, 225, 265, 269, 273], 'other': [224, 272], '7];': [227], 'prior': [229, 277, 461, 535], 'therapy': [232, 280], '3)': [234, 282], 'at': [237, 386, 393, 401, 446, 449, 478, 485], '60': [238, 479], 'mg/m2': [239, 244, 249, 255, 286, 299, 309, 320, 480], '(n': [240, 245, 250, 256, 290, 303, 313, 324, 352, 359, 368, 374], '1),': [242], '120': [243, 298, 308], '2),': [247], '240': [248, 285], '1)': [252], '480': [254], '7).': [258], 'B,': [261, 343], '14': [262], '(CRC': [264], '6];': [267, 275], 'ovarian': [268], '+': [287, 300, 310, 321, 511], 'AUC5': [289, 302, 323], '3;': [292, 305, 315], 'dose': [293, 379], 'level': [294], '[DL1]),': [296], 'DL2),': [306], 'AUC4': [312], 'DL3)': [316], '90': [319], '5;': [326], 'DL4).': [327], 'no': [331, 409, 431], 'dose-limiting': [332], 'toxicities': [333], '(DLT)': [334], 'or': [335, 658], 'drug-related': [336], 'G3-4': [337, 364, 382], 'AEs': [338, 365, 383], 'seen.': [340], 'had': [346, 532], 'DLT:': [347], 'G4': [348], 'neutropenia': [349, 367], 'fever': [351], '1;': [354, 361, 376], 'DL1)': [355], 'G3': [357], 'hypersensitivity': [358], 'DL2).': [362, 450], 'Non-DLT': [363], '4;': [370], 'DL1-2)': [371], 'thrombocytopenia': [373], 'DL2)': [377], 'requiring': [378], 'delays.': [380], 'No': [381], 'seen': [385, 439, 493], 'DL3-4.': [387], 'RP2D': [388], 'cohort': [389], 'expansion': [390], 'ongoing': [392, 519], 'DL4.': [394], 'displayed': [396], 'linear': [397], 'AUC': [398], 'Cmax': [400], 'all': [402], 'DLs;': [403], 'half-life': [405], '16h': [407], 'accumulation.': [410], 'Based': [411], 'preclinical': [413], 'models,': [414], 'efficacious': [415], 'exposures': [416], 'achieved.': [418], 'When': [419], 'combined': [420], 'CP,': [422, 549], 'DL1': [423], 'DL2': [425], 'similar': [427], 'exposure,': [429], 'suggesting': [430], 'apparent': [432], 'drug': [433], 'interactions.': [434], 'Decreased': [435], 'phosphorylation': [437], '2/2': [441], 'paired': [442], '(74%': [445], 'DL4;': [447], '94%': [448], 'An': [451], 'CRC': [453], 'pt': [454], '(serosal': [455], 'disease': [456, 490], 'abdominal': [458], 'lymphadenopathy;': [459], '3': [460], 'chemotherapy)': [464], 'complete': [466, 473], 'loss': [468], 'IHC': [470], 'achieved': [471], 'RECIST': [472, 488], 'remains': [482], '59+': [486], 'wks.': [487], 'stable': [489], '(SD)': [491], '4': [498], '(median': [500], 'duration': [501], 'SD': [503, 522], 'wks': [506], '[11-17.4': [507], 'wks])': [508], '7': [514], 'pts,': [515], 'who': [516, 531], 'still': [518], '(duration': [520], '5+': [524], '20+': [526], 'wks),': [527], 'including': [528, 573], 'several': [529], 'progressed': [533], 'platinum': [536], 'therapy.': [537], 'Conclusion:': [538], 'well': [541], 'tolerated': [542], 'monotherapy': [544, 656], 'combination': [547, 660], 'preliminary': [551, 670], 'target': [554, 673], 'modulation': [555, 674], 'will': [560], 'be': [561], 'further': [562], 'explored': [563], 'early': [565], 'II': [567], 'studies;': [568], 'multiple': [570], 'types,': [572], 'triple-negative': [574], 'breast': [575], 'cancer': [576, 666], 'non-small': [578], 'lung': [580], 'cancer;': [581], 'patients': [584, 667], 'DDR': [586], 'aberrations.': [587], 'Citation': [588], 'Format:': [589], 'Timothy': [590], 'A.': [591], 'Yap,': [592], 'Maria': [593], 'J.': [594], 'de': [595, 641], 'Miguel': [596], 'Luken,': [597], 'Brent': [598], "O'Carrigan,": [599], 'Desam': [600], 'Roda,': [601], 'Dionysis': [602], 'Papadatos-Pastos,': [603], 'David': [604], 'Lorente,': [605], 'Nina': [606], 'Tunariu,': [607], 'Raquel': [608], 'Perez': [609], 'Lopez,': [610], 'Sasha': [611], 'Gayle,': [612], 'Ruth': [613], 'Riisnaes,': [614], 'Ines': [615], 'Figueiredo,': [616], 'Susana': [617], 'Miranda,': [618], 'Suzanne': [619], 'Carreira,': [620], 'Fang': [621], 'Yang,': [622], 'Sharon': [623], 'Karan,': [624], 'Marina': [625], 'Penney,': [626], 'John': [627], 'Pollard,': [628], 'L.': [629], 'Rhoda': [630], 'Molife,': [631], 'Udai': [632], 'Banerji,': [633], 'Mohammed': [634], 'Asmal,': [635], 'Scott': [636], 'Z.': [637], 'Fields,': [638], 'Johann': [639], 'S.': [640], 'Bono.': [642], 'Phase': [643], 'first-in-class': [647], 'ataxia': [648], 'telangiectasia-mutated': [649], 'Rad3-related': [651], '(ATR)': [652], '(mono)': [657], 'carboplatin': [662], '(CP)': [663], '(pts)': [668], '[abstract].': [678], 'In:': [679], 'Proceedings': [680], 'AACR-NCI-EORTC': [683], 'International': [684], 'Conference:': [685], 'Molecular': [686], 'Targets': [687], 'Cancer': [689, 700], 'Therapeutics;': [690], '2015': [691], 'Nov': [692], '5-9;': [693], 'Boston,': [694], 'MA.': [695], 'Philadelphia': [696], '(PA):': [697], 'AACR;': [698], 'Mol': [699], 'Ther': [701], '2015;14(12': [702], 'Suppl': [703], '2):Abstract': [704], 'nr': [705], 'PR14.': [706]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2346506773', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 5}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 2}], 'updated_date': '2024-12-08T11:52:43.095280', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
